We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

99 hedge funds and large institutions have $559M invested in Avadel Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more call options, than puts

Call options by funds: $11M | Put options by funds: $3.37M

35% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 26

2% less funds holding

Funds holding: 101 → 99 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

23.25% less ownership

Funds ownership: 84.1% → 60.85% (-23%)

35% less capital invested

Capital invested by funds: $856M → $559M (-$297M)

Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
1.57%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
14
Increased
35
Reduced
26
Closed
16
Calls
$11M
Puts
$3.37M
Net Calls
+$7.59M
Net Calls Change
+$9.11M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$41.7M
2
TCM
Tang Capital Management
California
+$13.4M
3
RI
RTW Investments
New York
+$4.36M
4
MB
MPM BioImpact
Massachusetts
+$3.74M
5
KCM
Kennedy Capital Management
Missouri
+$3.6M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$12.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$11.1M
3
JMPWA
JP Morgan Private Wealth Advisors
California
-$8.24M
4
PCM
Portolan Capital Management
Massachusetts
-$4.78M
5
CAC
Cowen and Company
New York
-$4.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$2.94M +$313K +23,334 +9%
Bank of America
27
Bank of America
North Carolina
$2.29M +$2.4M +179,186 +420%
DMKJ
28
David M. Knott Jr
$2.29M -$252K -18,779 -8%
AR
29
Advisory Research
Illinois
$2.07M -$924K -68,968 -26%
JGC
30
J. Goldman & Co
New York
$1.68M +$1.8M +134,609 +468%
EWM
31
Edge Wealth Management
New York
$1.54M – – –
SCM
32
Soleus Capital Management
Connecticut
$1.07M -$2.72M -203,000 -66%
SC
33
Schulhoff & Co
Ohio
$989K – – –
Geode Capital Management
34
Geode Capital Management
Massachusetts
$972K +$188K +14,003 +17%
CIBC Private Wealth Group
35
CIBC Private Wealth Group
Georgia
$962K -$1.1K -82 -0.1%
CA
36
Cetera Advisors
Colorado
$905K +$1.18M +87,871 New
CM
37
Caption Management
Oklahoma
$835K +$186K +13,907 +21%
LPC
38
Lion Point Capital
New York
$824K +$1.07M +80,000 New
Commonwealth Equity Services
39
Commonwealth Equity Services
Massachusetts
$816K +$33.9K +2,528 +3%
BlackRock
40
BlackRock
New York
$808K +$336K +25,101 +47%
Two Sigma Investments
41
Two Sigma Investments
New York
$768K -$3.4M -254,204 -77%
MML Investors Services
42
MML Investors Services
Massachusetts
$748K +$294K +21,987 +43%
Millennium Management
43
Millennium Management
New York
$564K +$733K +54,726 New
JF
44
Jump Financial
Illinois
$552K +$717K +53,571 New
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$551K +$717K +53,523 New
IAM
46
Iridian Asset Management
Connecticut
$470K – – –
MCM
47
MAI Capital Management
Ohio
$466K -$81K -6,047 -12%
SOW
48
State of Wyoming
Wyoming
$431K +$91.6K +6,842 +20%
OC
49
Oppenheimer & Co
New York
$411K +$75.8K +5,663 +17%
State Street
50
State Street
Massachusetts
$312K +$99.1K +7,400 +32%
1
2
3 4 5

AVDL Hedge Fund Activity: Q3 2023 in Review

99 of the 6,304 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q3 2023, worth a combined $559M — down 35% from $856M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AVDL and 14 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 35 added.

The largest buyer was Janus Henderson Group, adding an estimated $41.7M. The largest seller was Adage Capital Partners, cutting an estimated $12.8M.

  • 99 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q3 2023, down from 101 in Q2 2023.
  • Funds reported $559M of Avadel Pharmaceuticals stock for Q3 2023, down 35% quarter-over-quarter.
  • 14 funds opened new Avadel Pharmaceuticals positions in Q3 2023 and 16 closed out, a net change of -2 holders.
  • The largest Avadel Pharmaceuticals buyer in Q3 2023 was Janus Henderson Group, an estimated $41.7M added.
  • The largest Avadel Pharmaceuticals seller in Q3 2023 was Adage Capital Partners, an estimated $12.8M sold.

Based on aggregated 13F filings for Q3 2023.